146 related articles for article (PubMed ID: 10548413)
1. Selective alkylatation of dopamine D2 and D4 receptors in rat brain by N-(p-isothiocyanatophenethyl)spiperone.
Zhang K; Tarazi FI; Kula NS; Baldessarini RJ; Neumeyer JL
Neurosci Lett; 1999 Oct; 274(3):155-8. PubMed ID: 10548413
[TBL] [Abstract][Full Text] [Related]
2. Alteration of dopamine transport in the striatum and nucleus accumbens of ovariectomized and estrogen-primed rats following N-(p-isothiocyanatophenethyl) spiperone (NIPS) treatment.
Thompson TL; Bridges SR; Weirs WJ
Brain Res Bull; 2001 Apr; 54(6):631-8. PubMed ID: 11403989
[TBL] [Abstract][Full Text] [Related]
3. Effects of alkylating agents on dopamine D(3) receptors in rat brain: selective protection by dopamine.
Zhang K; Weiss NT; Tarazi FI; Kula NS; Baldessarini RJ
Brain Res; 1999 Nov; 847(1):32-7. PubMed ID: 10564733
[TBL] [Abstract][Full Text] [Related]
4. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
Xu SX; Hatada Y; Black LE; Creese I; Sibley DR
J Pharmacol Exp Ther; 1991 May; 257(2):608-15. PubMed ID: 1674530
[TBL] [Abstract][Full Text] [Related]
5. Prolonged D2 antidopaminergic activity of alkylating and nonalkylating derivatives of spiperone in rat brain.
Baldessarini RJ; Kula NS; Campbell A; Bakthavachalam V; Yuan J; Neumeyer JL
Mol Pharmacol; 1992 Nov; 42(5):856-63. PubMed ID: 1435753
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization and autoradiographic localization of a putative dopamine D4 receptor in the heart.
Ricci A; Bronzetti E; Fedele F; Ferrante F; Zaccheo D; Amenta F
J Auton Pharmacol; 1998 Apr; 18(2):115-21. PubMed ID: 9730266
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
Newman-Tancredi A; Cussac D; Brocco M; Rivet JM; Chaput C; Touzard M; Pasteau V; Millan MJ
Brain Res; 2001 Nov; 920(1-2):41-54. PubMed ID: 11716810
[TBL] [Abstract][Full Text] [Related]
8. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic effects of isofloxythepin on dopamine D1 and D2 receptors and behaviors in rats.
Lau YS; Fung YK; Anderson TM
Gen Pharmacol; 1997 Nov; 29(5):729-36. PubMed ID: 9347318
[TBL] [Abstract][Full Text] [Related]
10. Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat.
Szczepanik AM; Wilmot CA
Neurosci Lett; 1997 Aug; 231(2):91-4. PubMed ID: 9291148
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological and functional characterisation of dopamine D4 receptors in the rat retina.
Patel S; Chapman KL; Marston D; Hutson PH; Ragan CI
Neuropharmacology; 2003 Jun; 44(8):1038-46. PubMed ID: 12763097
[TBL] [Abstract][Full Text] [Related]
12. Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands.
Kula NS; Tarazi FI; Baldessarini RJ; Xu L; Bakthavachalam V; Pounds S; True CD
Eur J Pharmacol; 1999 Feb; 367(1):139-42. PubMed ID: 10082277
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.
Leysen JE; Gommeren W; Mertens J; Luyten WH; Pauwels PJ; Ewert M; Seeburg P
Psychopharmacology (Berl); 1993; 110(1-2):27-36. PubMed ID: 7870895
[TBL] [Abstract][Full Text] [Related]
14. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
[TBL] [Abstract][Full Text] [Related]
15. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
Sumiyoshi T; Ichikawa J; Meltzer HY
Neuropsychopharmacology; 1997 Mar; 16(3):183-90. PubMed ID: 9138434
[TBL] [Abstract][Full Text] [Related]
16. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion.
Neisewander JL; O'Dell LE; Redmond JC
Brain Res; 1995 Feb; 671(2):201-12. PubMed ID: 7743209
[TBL] [Abstract][Full Text] [Related]
17. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
Primus RJ; Thurkauf A; Xu J; Yevich E; McInerney S; Shaw K; Tallman JF; Gallagher DW
J Pharmacol Exp Ther; 1997 Aug; 282(2):1020-7. PubMed ID: 9262371
[TBL] [Abstract][Full Text] [Related]
18. Regional distribution of dopamine D4 receptors in rat forebrain.
Tarazi FI; Kula NS; Baldessarini RJ
Neuroreport; 1997 Nov; 8(16):3423-6. PubMed ID: 9427299
[TBL] [Abstract][Full Text] [Related]
19. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
Schetz JA; Chu A; Sibley DR
J Pharmacol Exp Ther; 1999 May; 289(2):956-64. PubMed ID: 10215675
[TBL] [Abstract][Full Text] [Related]
20. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
Gackenheimer SL; Schaus JM; Gehlert DR
J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
